We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Onzima Ventures | LSE:ONZ | London | Ordinary Share | GB00BYQCDH57 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/7/2016 22:48 | RAMPER, Nice blatant lie of yours by the way. | fido | |
21/7/2016 22:11 | No, clearly he isn't going to post it for you, so nice try acting like anyone cares whether you believe it. Why would a shell pay a loan off to acquire a company of 0 value? | wahlberg | |
21/7/2016 21:42 | bigego, So you really are not going to post it are you. I will take it from that that its because it don`t exist, however I will double check but I already know what the answer will be and that is you made it up. With regard your other questions, I will not be negotiating at all, that will be down to the CEO and Nigel if they are both agreeable. I will only introduce the option to them and if its a goer then it will be subject to an EGM at the shell. As for contracts, ONZ is just a stakeholder of N4. The only contract as such is for the loan provided to N4 by ONZ which could very easily be paid back from shell funds. | fido | |
21/7/2016 20:20 | Very true Wahlberg N4 could be a £500m mcap company in the making. The potential if the platform delivers is about the best I have ever scene on AIM. | bigego | |
21/7/2016 19:38 | “Once we demonstrate that we can do it, we will be able to commercialise the technology by getting licensing deals with large pharmaceuticals companies." “Those deals will enable us to fund a clinical programme to measure our technology against the existing drug." Mr Theobald has a solid track record in the industry. The flexibility of his model is that each of the company’s innovations can be funded individually on a stand-alone basis, with different sources and quantum of capital dependent on the particular requirements of the drug candidate or prospective product. The strength of the business is the clever way it has been pieced together. “We have a reformulation and a vaccine play and in Opal the patent expertise,” he says of N4. “It is a new way of putting together a small healthcare company, but one I think is going to work very well and can quickly become a large healthcare company.” NT thinks n4 can quickly become a large healthcare company, and I do too. The value of ONZIMA will really appreciate from here onwards | wahlberg | |
21/7/2016 19:26 | Bigego - don't do him any favour whatsoever to provide the information. Regarding the investing policy, you're correct - that is a little issue. Little because the company can quite easily change it. | wahlberg | |
21/7/2016 19:16 | Of course you also have the little issue of non resource stocks not being able to make up more than 25% of ONZ which is of course an oil & gas investment company. | fido | |
21/7/2016 19:12 | And one that asks a simple question that no one wants to answer. Perhaps because all the RAMPING on the back of it was a complete lie. Easy to resolve, post where it says ONZ have first option on the other 51% of N4. | fido | |
21/7/2016 19:05 | Having read your posts here and on your Twitter account you really are a bitter and deluded individual IMHO . . . | cufes2 | |
21/7/2016 18:44 | bigego, So you`re still not going to post it then. One might think all this rubbish about contracts was a blatant lie. | fido | |
21/7/2016 17:20 | He's like a little boy lost playing out his nasty tantrums in a mans world. Bet he would still be on the nipple if circumstances allowed. | bigego | |
21/7/2016 17:16 | 7 Duckworth Lane, Rossendale, Lancashire, BB4 6JN Still living here Dave? | wahlberg | |
21/7/2016 17:15 | RAMPER. If I were to set up a business from scratch, the fact that I would have a website and a marketing spend would mean that I would have the "potential" to sell worldwide. That "potential" would give me the "potential" of becoming a multi billion pound company. Easy to say isn`t it. | fido | |
21/7/2016 17:11 | Getting back to that other 51% for a moment. In the same interview Nigel mentioned a host of other options for bringing N4 to market. I would have thought that if what you said was true then ONZ would have a veto on N4 using any other route. If what you say is just made up and a blatant lie then..... Either way I will check. | fido | |
21/7/2016 17:07 | RAMPER, What Nigel actually said according to a newspaper article (LOL) was "potential" to become a 500m company. It goes without saying that if Nigel fails to secure a deal then N4 will almost certainly go bust and take ONZ with it. | fido | |
21/7/2016 17:03 | Bigego, he probably buys those half-loafs - given he is surely a psychotic loner. | wahlberg | |
21/7/2016 16:59 | Yes, assume it is made up because you are too stupid to find it. Just like the £500m quote. I'm sure bigego couldn't give a sh!t. | wahlberg | |
21/7/2016 16:44 | bigego, So you are not going to post it then. I will double check but in the interim I will assume that it is made up like the many other lies and exaggerations posted by the RAMPERS on this board. | fido | |
21/7/2016 15:30 | For someone who now spends almost their entire day searching #ONZ and posting drivel, you could have done some basic research Onz have the right to acquire the remaining 51% | wahlberg | |
21/7/2016 14:55 | Bigego, There is no first option of the other 51%. If there is then produce it. | fido | |
21/7/2016 14:52 | Outrageous :) | patientcapital |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions